Made available in DSpace on 2014-10-09T12:27:57Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T14:00:54Z (GMT). No. of bitstreams: 0 / Tese (Doutoramento) / IPEN/T / Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP

Devant l’augmentation de l’incidence des cancers de prostate de faible risque, les thérapies focales apparaissent comme une alternative séduisante entre la surveillance active et les traitements radicaux classiques. Les thérapies Laser (Thérapie photodynamique [PDT] et thermothérapie laser interstitielle [LITT]) pourraient être des modalités d’application de cette thérapie focale.Dans la première partie de cette thèse, nous discutons du concept de thérapie focale, et de la place des thérapies Laser par rapport aux différentes autres modalités énergétiques. Le premier chapitre de cette partie est consacré à l’émergence de la thérapie focale, à ses bases histopathologiques et à l’importance de l’imagerie dans son application. L’échographie et l’imagerie par résonance magnétique (IRM) représentent des outils indispensables pour l’aide au diagnostic, la sélection des patients et le guidage du traitement focal. Les avantages et inconvénients ainsi que les principaux résultats cliniques des différentes modalités énergétiques utilisées pour la thérapie focale sont présentés dans le deuxième chapitre de cette partie. Nous dressons un état de l’art de la PDT et de la LITT pour le traitement focal dans un troisième chapitre. Ces thérapeutiques Laser sont actuellement en développement clinique. Ces deux modalités de traitement reposent sur des principes physiques différents, mais leur application à la thérapie focale pose des problématiques identiques (planification dosimétrique, guidage du traitement interstitiel). Nous précisons les développements actuellement en cours pour résoudre ces problématiques et notamment les travaux de notre unité de recherche. La deuxième partie de cette thèse est dédiée au développement expérimental de LITT pour le cancer de prostate menée au sein de notre unité de recherche. Dans le premier chapitre de cette partie, nous présentons la mise en place d’un modèle animal (Rat Copenhagen avec greffe hétérotopique d’un adénocarcinome prostatique syngénique Dunning R3327-AT2) adapté au traitement par LITT focale. Nous décrivons le monitoring de cette thérapie sous IRM et échographie et démontrons la reproductibilité des volumes de nécrose induits pour un niveau d’énergie donné. Le deuxième chapitre de cette partie est consacré à la mise en place d’un outils de planification dosimétrique adapté à notre modèle in vivo et basé sur la diffusion de chaleur au sein des tissus et au calcul des dommages cellulaires. Enfin dans le troisième chapitre, nous proposons la mise en place d’un fantôme de prostate anatomiquement valide permettant de simuler et d’expérimenter des procédures focales de LITT. Ce fantôme compatible avec un monitoring sous échographie et sous IRM pourrait également être utilisé pour le développement d’autres modalités énergétiques de thérapie focale. / Given the increased incidence of prostate cancer low-risk, focal therapies appear as an attractive alternative between active surveillance and radical treatments. Laser therapies (photodynamic therapy [PDT] and interstitial laser thermotherapy [LITT]) could be modalities of application of this focal therapy.In the first section of this thesis, we discuss the concept of focal therapy, and the place of laser therapies compared to several other energy modalities. The first chapter of this section is devoted to the emergence of focal therapy, its histopathologic bases and the importance of imaging in its application. Ultrasonography and magnetic resonance imaging (MRI) are essential tools to aid diagnosis, patient selection and guidance of focal treatment. The advantages and disadvantages and the main clinical outcomes of different energy modalities used for focal therapy are presented in the second chapter of this section. We summarize a state of the art of PDT and LITT for the focal treatment in a third chapter. These Laser therapies are currently in clinical development. Both treatment modalities are based on different physical principles but their application to focal therapy raises identical issues (treatment planning, guiding interstitial treatment). We specify the developments currently underway to address these issues and particularly the work of our research unit.The second section of this thesis is dedicated to the experimental development of LITT for prostate cancer conducted in our research unit. In the first chapter of this section, we present the development of an animal model (rat Copenhagen with heterotopic and syngenic prostatic adenocarcinoma transplant Dunning R3327 -AT2) for processing focal LITT. We describe the monitoring of this therapy under ultrasonography and MRI and demonstrate the reproducibility of the volumes of necrosis induced for one given energy level. The second chapter of this section is devoted to the establishment of a treatment planning tools adapted to our in vivo model and based on tissue heat diffusion and calculation of induced cell damages. Finally in the third chapter, we propose the establishment of an anatomically valid prostate phantom to simulate and test focal LITT procedures. This phantom compatible with ultrasonography and MRI monitoring could also be used for the development of other focal therapy energy modalities.

Recent progress in nanotechnology has attracted interest to a biomedical application of the carbon nanoparticle C60 fullerene (C60) due to its unique structure and versatile biological activity. In the current study the dual functionality of C60 as a photosensitizer and a drug nanocarrier was exploited to improve the efficiency of chemotherapeutic drugs towards human leukemic cells. Pristine C60 demonstrated time-dependent accumulation with predominant mitochondrial localization in leukemic cells. C60’s effects on leukemic cells irradiated with high power single chip LEDs of different wavelengths were assessed to find out the most effective photoexcitation conditions. A C60-based noncovalent nanosized system as a carrier for an optimized drug delivery to the cells was evaluated in accordance to its physicochemical properties and toxic effects. Finally, nanomolar amounts of C60-drug nanocomplexes in 1:1 and 2:1 molar ratios were explored to improve the efficiency of cell treatment, complementing it with photodynamic approach. A proposed treatment strategy was developed for C60 nanocomplexes with the common chemotherapeutic drug Doxorubicin, whose intracellular accumulation and localization, cytotoxicity and mechanism of action were investigated. The developed strategy was revealed to be transferable to an alternative potent anticancer drug – the herbal alkaloid Berberine. Hereafter, a strong synergy of treatments arising from the combination of C60-mediated drug delivery and C60 photoexcitation was revealed. Presented data indicate that a combination of chemo- and photodynamic treatments with C60-drug nanoformulations could provide a promising synergetic approach for cancer treatment. / Kürzliche Fortschritte in der Nanotechnologie haben Interesse an einer biomedizinischen Anwendung des Kohlenstoffnanopartikels C60 Fulleren (C60) aufgrund seiner einzigartigen Struktur und breiten biologischen Aktivität geweckt. In der aktuellen Studie wurde die doppelte Funktionalität von C60 als Photosensibilisator und als Wirkstoff-Nanoträger genutzt, um die Wirkung von Chemotherapeutika auf menschliche Leukämiezellen zu verbessern. C60 alleine zeigte in den Zellen eine zeitabhängige Akkumulation mit vorherrschender mitochondrialer Lokalisation. Die Wirkung von C60 auf Leukämiezellen, die mit unterschiedlicher Wellenlänge bestrahlt wurden, wurde bewertet, um die effektivsten Photoanregungsbedingungen zu finden. Die physikochemischen Eigenschaften und toxischen Wirkungen von C60 auf die Leukämiezellen wurden nach nicht kovalenter Bindung von Arzneistoffen bewertet. Schließlich wurden nanomolare Mengen von C60-Wirkstoff-Nanokomplexen in Molverhältnissen von 1:1 und 2:1 untersucht, um die Effizienz der Behandlung von Zellen zu verbessern und sie durch photodynamischen Ansatz zu ergänzen. Mit dem gängigen Chemotherapeutikum Doxorubicin wurde eine Behandlungsstrategie entwickelt und dessen intrazelluläre Akkumulation und Lokalisation, Zytotoxizität und Wirkmechanismus untersucht wurden. Es wurde gezeigt, dass die entwickelte Strategie auch auf ein alternatives Krebsmedikament übertragbar ist – das pflanzliche Alkaloid Berberin. Die erhaltenen Daten deuten darauf hin, dass eine Kombination von chemo- und photodynamischen Behandlungen mit C60-Nanokomplexen einen vielversprechenden synergetischen Ansatz für die Krebsbehandlung bieten könnte.

No description available.

No description available.

No description available.

No description available.

Yes / Photodynamic Therapy (PDT) is an emerging method to treat colorectal cancers (CRC). Hypericin (HYP) is an effective mediator of PDT and the ABCG2 inhibitor, Febuxostat (FBX) could augment PDT. HT29 and HEK293 cells showed light dependant cytotoxic response to PDT in both 2D and 3D cell models. FBX co-treatment was not found to improve PDT cytotoxicity. Next, ABCG2 protein expression was observed in HT29 but not in HEK293 cells. However, ABCG2 gene expression analysis did not support protein expression results as ABCG2 gene expression results were found to be higher in HEK293 cells. Although HYP treatment was found to significantly reduce ABCG2 gene expression levels in both cell lines, FBX treatment partially restored ABCG2 gene expression. Our findings indicate that FBX co-treatment may not be suitable for augmenting HYP-mediated PDT in CRC but could potentially be useful for other applications. / Royal Society International Exchanges Award (IEC\R3\203014) - UKRI EPSRC Research Programme Grant (753910/B19R13527) - Bowel Cancer UK/RCS Eng Colorectal Research Chair Award (18SC0001) / The full-text of this article will be released for public view at the end of the publisher embargo on 16 Apr 2025.

This PhD project has explored the use of novel nitroxide annulated porphyrinic macrocycles as photosensitisers (PSs) for photodynamic therapy (PDT). The PSs have been synthesised, structurally, photophysically and photochemically characterised and investigated biologically through cell assays to determine their potential as photoactivated anticancer drugs. Tetra-nitroxide annulated phthalocyanines (Pcs) were initially investigated. Each of these compounds exhibit four annulated nitroxide-containing rings in a rigid, planar arrangement with fixed distance and geometry with respect to the macrocycle core, which is a novel structural motif in Pc chemistry. The presence of the nitroxides purportedly has two effects: to quench fluorescence and to increase photochemical singlet oxygen production by the compound. While nitroxides, as paramagnetic compounds, are non-fluorescent, their reduction to diamagnetic hydroxylamines results in an increased fluorescence yield. In this way, the nitroxide Pcs can potentially be used as probes for metabolic activity in biological systems, where the primary fate of the nitroxide moiety is reduction. Here, the fluorescence properties of the nitroxide-annulated Pcs were investigated through reduction of the nitroxide moieties by biologically significant reductants and calculation of fluorescence quantum yields. The singlet oxygen quantum yields of the Pcs were determined by two methods, the chemical trapping of singlet oxygen and the direct observation of singlet oxygen luminescence. While the quantum yields of the Pcs were promising when compared to clinically relevant PSs, the tetra-nitroxide Pcs did not exhibit increased quantum yields with respect to their nitroxide-free analogues. Additionally, there was minimal photodynamic action in cell assays. Subsequent fluorescence microscopy confirmed that this was most probably due to the fact that the Pcs were not localising within the cells. To improve the photodynamic action of the Pcs, two polymer-based delivery strategies were employed to enhance their delivery in biological environments. Firstly, the nitroxide Pcs were coupled to linear polymers to create polymer Pc hybrids. The second method involved the encapsulation of the nitroxide Pcs within polymer-based micelles. The synthesis of the polymer Pc hybrids was via a fast and efficient Atom Transfer Nitroxide Radical Coupling (ATNRC) reaction. The hybrids were synthesised as Mg, Zn or free-base (2H) Pc complexes, with either hydrophobic or hydrophilic polymer arms. The hybrids displayed high fluorescence quantum yields and reasonable singlet oxygen quantum yields. Again, these attributes this did not extend to any cell growth inhibition, even for the hydrophilic derivatives. Micellisation of the Pcs with a poly(styrene)-poly(acrylic acid) (PSty-PAA) star diblock copolymer afforded micelles with a range of concentrations of Pcs encapsulated within the glassy PSty core. Fluorescence studies showed that the micelles protected the nitroxide moieties from reduction by ascorbate, a result that could find application in EPR imaging and oximetry. During singlet oxygen experiments, the micelles were found to perform as nanoreactors, supramolecular assemblies which provide a reaction volume for other reagents. Pcs in the micelle cores effectively generated singlet oxygen and while this failed to escape the micelles, it was very effective in the oxidation of a hydrophobic model compound. Although there are potential applications for the micelle systems in waste-water remediation, these systems were ineffective in the PDT assays. With the difficulties associated with the biological delivery of the nitroxide Pcs in mind, hydrophilic mono-nitroxide annulated porphyrazine (Pz) macrocycles were designed and synthesised. Pzs exhibit many of the favourable optical properties of the Pcs. Synthesis of these compounds proceeded via Linstead macrocyclisation to give the target MgPz with A3B type substitution. A nitroxide-free A4 Pz was also isolated as a side-product. Transmetallation and/or hydrolysis gave access to Mg and Zn A3B and A4 carboxylate Pzs. These compounds were structurally characterised and their fluorescence characteristics investigated. The 1O2 quantum yields of the Pzs were also studied. Significantly, nitroxide annulation was found to enhance 1O2 generation of the Pzs relative to nitroxide-free analogues. The Zn carboxylate Pzs were shown to effectively inhibit the growth of tumour cell lines in PDT assay and the MgA4 carboxylate displayed strong 2-photon fluorescence within the cytoplasm of NFF cells. Experiments on freshly excised skin showed the carboxylate Pzs to be highly effective 2-photon PSs for PDT. In conclusion, we have identified several carboxylate Pzs which should be tested further in in vivo PDT experiments.

Submitted by Ligia Souza (ligia@ufscar.br) on 2017-09-21T14:27:46Z No. of bitstreams: 1 TeseMCG.pdf: 3682312 bytes, checksum: fd17a7f18e76507395baaaf315348805 (MD5) / Approved for entry into archive by Ronildo Prado (ronisp@ufscar.br) on 2017-09-25T12:32:38Z (GMT) No. of bitstreams: 1 TeseMCG.pdf: 3682312 bytes, checksum: fd17a7f18e76507395baaaf315348805 (MD5) / Approved for entry into archive by Ronildo Prado (ronisp@ufscar.br) on 2017-09-25T12:32:44Z (GMT) No. of bitstreams: 1 TeseMCG.pdf: 3682312 bytes, checksum: fd17a7f18e76507395baaaf315348805 (MD5) / Made available in DSpace on 2017-09-25T12:37:57Z (GMT). No. of bitstreams: 1 TeseMCG.pdf: 3682312 bytes, checksum: fd17a7f18e76507395baaaf315348805 (MD5) Previous issue date: 2017-07-31 / Outra / Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / Infectious pneumonia is a major cause of morbidity/mortality, mainly due to the increasing rate of microorganisms resistant to antibiotics. Photodynamic Inactivation (PDI) is emerging as a promising approach, as effects are based on oxidative stress, preventing the emergence of resistant microorganism strains. In previous studies, the in vitro inactivation of Streptococcus pneumoniae using indocyanine green (ICG) and infrared light source was successful, and achieved reduction of 5 log10 colony-forming units (CFU/mL) with concentration as low as 10 μM ICG. In the present study, a proof-of-principle protocol was designed to treat lung infections by PDI using extracorporeal illumination with a 780 nm laser device and ICG as photosensitizer. In a first row of experiments, hairless mice were infected with S. pneumoniae and PDI was performed two days after infection. For control groups, CFU recovery ranged between 103-104 CFU/mL/mouse. For PDT group, however, no bacteria were recovered in 80% of the animals. Animal survival was evaluated separately over 50 days. No deaths occurred in PDT group, whereas 60% of the control did not survive. Lung injury analyses were performed in BALB/c mice, the bacteria reduction were 2 and 4 log10 in 2 mice (5 in total) and the wet-to-dry ratio showed that PDI did not increase the edema in lungs. The bronchoalveolar lavage data indicated a larger absolute number of cells (mononuclear and polymorphonuclear) in the PDI group in contrast to control group, meaning that the technique could increase the immune system response. In vitro results showed the irradiated ICG could generate aggregates or photoproducts that help PDI to inactivate the bacteria. Our results indicate that extracorporeal PDI has potential for pneumonia treatment, and pulmonary decontamination with PDI may be used as a single therapy or as an antibiotics adjuvant. / A pneumonia infecciosa é uma das principais causas de morbidade/mortalidade no mundo, principalmente devido à taxa crescente de micro-organismos resistentes a antibióticos. A inativação fotodinâmica (IFD) está emergindo como uma abordagem promissora, cujos efeitos são baseados no estresse oxidativo, impedindo o surgimento de cepas de micro-organismos resistentes. Em estudos anteriores, a inativação in vitro de Streptococcus pneumoniae utilizando indocianina verde (ICV) e fonte de luz de infravermelho foi efetiva, inativando 5 log10 (UFC/mL) com apenas 10 μM ICV. Neste estudo, foi avaliado protocolo de prova de princípio para tratar infecções pulmonares por IFD usando irradiação extracorpórea com dispositivo a laser emitindo em 780 nm e ICV como fotossensibilizador (FS). Em uma primeira série de experimentos, camundongos hairless SKH-1 foram infectados com S. pneumoniae e a IFD foi realizada dois dias após a infecção. Para os grupos de controles, a recuperação de UFC variou entre 103-104 UFC/mL/animal. Para o grupo IFD, no entanto, nenhuma bactéria foi recuperada em 80% dos animais. A sobrevivência animal foi avaliada durante 50 dias. Não ocorreram mortes no grupo IFD, enquanto 60% do grupo controle foi a óbito. Foram realizadas análises de lesões pulmonares em camundongos BALB/c, onde a redução bacteriana foi de 2 e 4 log10 em dois animais (total 5) em comparação com o grupo controle, e a proporção de peso úmido e seco mostrou que a IFD não aumentou o edema nos pulmões. Os dados de lavagem broncoalveolar indicaram um aumento no número absoluto de células (mononucleares e polimorfonucleares) no grupo IFD, o que indica que a técnica pode aumentar a resposta do sistema imunológico. Os resultados in vitro mostraram que a ICV irradiada pode gerar agregados ou fotoprodutos que auxiliam a IFD a inativar a bactéria. Os resultados deste estudo indicam que a IFD com irradiação extracorpórea tem potencial para o tratamento de pneumonia, e a descontaminação pulmonar com IFD pode ser usada como terapia ou como adjuvante aos antibióticos. / CAPES: 99999.003154/2015-07